ClinicalTrials.gov
public full text
Public Domain
Hematological Dynamic Scores for Predicting Survival and Treatment Response for Advanced Gastric Cancer After Neoadjuvant Therapy
gastric-cancerinflammationneoadjuvant-chemotherapyoxidative-stressrisk-stratificationtreatment-response
HMDLS, based on hematological markers, could effectively distinguish the long-term efficacy of AGC patients after NAT. The predictive performance of nomogram-HMDLS was better than ypTNM stage, achieving better prognostic stratification and tumor treatment response prediction.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ML Decision Model for G-NEC Adjuvant Therapy#856238
- The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.#868941
- Advanced Gastric Cancer. Results Observed in a Private Regional Health Center#936052
- The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling#896620
- PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer#860077
Record · ID 1371569
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive